Table 3. Pathways significantly overrepresented in the genes differentially expressed in cluster headache.
Pathway | Threshold DEGs P < 0.05 |
Threshold DEGs P < 0.01 |
||
---|---|---|---|---|
P-value | Count | P-value | Count | |
GABA Receptor Signaling | 0.00053 | 13 | 0.043 | 4 |
Calcium-induced T Lymphocyte Apoptosis | 0.0015 | 18 | 0.028 | 6 |
Nur77 Signaling in T Lymphocytes | 0.0066 | 15 | 0.0040 | 7 |
CD28 Signaling in T Helper Cells | 0.0098 | 28 | 0.021 | 10 |
Cdc42 Signaling | 0.015 | 29 | 0.014 | 11 |
Role of BRCA1 in DNA Damage Response | 0.017 | 21 | 0.023 | 8 |
IGF-1 Signaling | 0.022 | 24 | 0.025 | 9 |
Actin Nucleation by ARP-WASP Complex | 0.023 | 15 | 0.0083 | 7 |
Prolactin Signaling | 0.026 | 19 | 0.041 | 7 |
IL-4 Signaling | 0.026 | 19 | 0.041 | 7 |
PTEN Signaling | 0.043 | 25 | 0.045 | 9 |
Telomerase Signaling | 0.044 | 23 | 0.026 | 9 |
P-value thresholds for differential gene expression are P < 0.05 and P < 0.01. Pathways are included if overrepresented in lists of differentially expressed genes based on both P-value thresholds. DEGs: differentially expressed genes.